Alan S Go1,2,3, Chi-Yuan Hsu4,3, Jingrong Yang4, Thida C Tan4, Sijie Zheng5, Juan D Ordonez5, Kathleen D Liu3. 1. Division of Research, Kaiser Permanente Northern California, Oakland, California; Alan.S.Go@kp.org. 2. Department of Epidemiology and Biostatistics and. 3. Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California; and. 4. Division of Research, Kaiser Permanente Northern California, Oakland, California. 5. Division of Nephrology, Kaiser Permanente Oakland Medical Center, Oakland, California.
Abstract
BACKGROUND AND OBJECTIVES: AKI in the hospital is common and is associated with excess mortality. We examined whether AKI is also independently associated with a higher risk of different cardiovascular events in the first year after discharge. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective analysis of a cohort between 2006 and 2013 with follow-up through 2014, within Kaiser Permanente Northern California. We identified all adults admitted to 21 hospitals who had one or more in-hospital serum creatinine test result and survived to discharge. Occurrence of AKI was on the basis of Kidney Disease: Improving Global Outcomes diagnostic criteria. Potential confounders were identified from comprehensive inpatient and outpatient, laboratory, and pharmacy electronic medical records. During the 365 days after discharge, we ascertained occurrence of heart failure, acute coronary syndromes, peripheral artery disease, and ischemic stroke events from electronic medical records. RESULTS: Among a matched cohort of 146,941 hospitalized adults, 31,245 experienced AKI. At 365 days postdischarge, AKI was independently associated with higher rates of the composite outcome of hospitalization for heart failure and atherosclerotic events (adjusted hazard ratio [aHR], 1.18; 95% confidence interval [95% CI], 1.13 to 1.25) even after adjustment for demographics, comorbidities, preadmission eGFR and proteinuria, heart failure and sepsis complicating the hospitalization, intensive care unit (ICU) admission, length of stay, and predicted in-hospital mortality. This was driven by an excess risk of subsequent heart failure (aHR, 1.44; 95% CI, 1.33 to 1.56), whereas there was no significant association with follow-up atherosclerotic events (aHR, 1.05; 95% CI, 0.98 to 1.12). CONCLUSIONS: AKI is independently associated with a higher risk of cardiovascular events, especially heart failure, after hospital discharge.
BACKGROUND AND OBJECTIVES: AKI in the hospital is common and is associated with excess mortality. We examined whether AKI is also independently associated with a higher risk of different cardiovascular events in the first year after discharge. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective analysis of a cohort between 2006 and 2013 with follow-up through 2014, within Kaiser Permanente Northern California. We identified all adults admitted to 21 hospitals who had one or more in-hospital serum creatinine test result and survived to discharge. Occurrence of AKI was on the basis of Kidney Disease: Improving Global Outcomes diagnostic criteria. Potential confounders were identified from comprehensive inpatient and outpatient, laboratory, and pharmacy electronic medical records. During the 365 days after discharge, we ascertained occurrence of heart failure, acute coronary syndromes, peripheral artery disease, and ischemic stroke events from electronic medical records. RESULTS: Among a matched cohort of 146,941 hospitalized adults, 31,245 experienced AKI. At 365 days postdischarge, AKI was independently associated with higher rates of the composite outcome of hospitalization for heart failure and atherosclerotic events (adjusted hazard ratio [aHR], 1.18; 95% confidence interval [95% CI], 1.13 to 1.25) even after adjustment for demographics, comorbidities, preadmission eGFR and proteinuria, heart failure and sepsis complicating the hospitalization, intensive care unit (ICU) admission, length of stay, and predicted in-hospital mortality. This was driven by an excess risk of subsequent heart failure (aHR, 1.44; 95% CI, 1.33 to 1.56), whereas there was no significant association with follow-up atherosclerotic events (aHR, 1.05; 95% CI, 0.98 to 1.12). CONCLUSIONS: AKI is independently associated with a higher risk of cardiovascular events, especially heart failure, after hospital discharge.
Authors: Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak Journal: Circulation Date: 2006-06-05 Impact factor: 29.690
Authors: Chirag R Parikh; Jeremy Puthumana; Michael G Shlipak; Jay L Koyner; Heather Thiessen-Philbrook; Eric McArthur; Kathleen Kerr; Peter Kavsak; Richard P Whitlock; Amit X Garg; Steven G Coca Journal: J Am Soc Nephrol Date: 2017-08-14 Impact factor: 10.121
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Mitchell S V Elkind; Cara L Carty; Ellen S O'Meara; Thomas Lumley; David Lefkowitz; Richard A Kronmal; W T Longstreth Journal: Stroke Date: 2011-05-05 Impact factor: 7.914
Authors: Matthew T James; Susan M Samuel; Megan A Manning; Marcello Tonelli; William A Ghali; Peter Faris; Merril L Knudtson; Neesh Pannu; Brenda R Hemmelgarn Journal: Circ Cardiovasc Interv Date: 2013-01-15 Impact factor: 6.546
Authors: Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu Journal: J Am Soc Nephrol Date: 2012-12-06 Impact factor: 10.121
Authors: Gabriel J Escobar; John D Greene; Peter Scheirer; Marla N Gardner; David Draper; Patricia Kipnis Journal: Med Care Date: 2008-03 Impact factor: 2.983
Authors: Chi-Yuan Hsu; Raymond K Hsu; Kathleen D Liu; Jingrong Yang; Amanda Anderson; Jing Chen; Vernon M Chinchilli; Harold I Feldman; Amit X Garg; Lee Hamm; Jonathan Himmelfarb; James S Kaufman; John W Kusek; Chirag R Parikh; Ana C Ricardo; Sylvia E Rosas; Georges Saab; Daohang Sha; Edward D Siew; James Sondheimer; Jonathan J Taliercio; Wei Yang; Alan S Go Journal: J Am Soc Nephrol Date: 2019-06-24 Impact factor: 10.121
Authors: Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew Journal: JAMA Intern Med Date: 2020-03-01 Impact factor: 21.873
Authors: Yang Chen; Gail J Harty; Ye Zheng; Seethalakshmi R Iyer; Shinobu Sugihara; S Jeson Sangaralingham; Tomoko Ichiki; Joseph P Grande; Hon-Chi Lee; Xiaoli Wang; John C Burnett Journal: Circ Res Date: 2019-05-10 Impact factor: 17.367
Authors: Jeremie M Lever; Travis D Hull; Ravindra Boddu; Mark E Pepin; Laurence M Black; Oreoluwa O Adedoyin; Zhengqin Yang; Amie M Traylor; Yanlin Jiang; Zhang Li; Jacelyn E Peabody; Hannah E Eckenrode; David K Crossman; Michael R Crowley; Subhashini Bolisetty; Kurt A Zimmerman; Adam R Wende; Michal Mrug; Bradley K Yoder; Anupam Agarwal; James F George Journal: JCI Insight Date: 2019-01-24
Authors: Yang Xu; Aditya Surapaneni; Jim Alkas; Marie Evans; Jung-Im Shin; Elizabeth Selvin; Alex Chang; Morgan E Grams; Juan Jesus Carrero Journal: Diabetes Care Date: 2020-10-06 Impact factor: 19.112
Authors: Chi-Yuan Hsu; Rishi V Parikh; Leonid N Pravoverov; Sijie Zheng; David V Glidden; Thida C Tan; Alan S Go Journal: JAMA Intern Med Date: 2020-12-01 Impact factor: 21.873